Increasing evidence has demonstrated that ESRP1 dysregulation is closely correlated with the tumorigenesis and progression of various types of cancers, including ovarian cancer [16], breast cancer [17], prostate cancer [18], colorectal cancer [19], lung cancer [20] and so forth. Here, ESRP1 is linked to breast carcinoma.